- MyFiziq’s (MYQ) joint venture, Body Composition Technologies (BCT), has placed second at the DXC Invitational Americas Insurtech awards
- The new tech company was one of four finalists at the second-ever DXC awards, taking out the second spot in category two
- BCT is a software platform which allows consumers to create reliable smartphone-based body compositions to be utilised by governments . and insurance agencies
- Company shares remained flat today, closing at 32 cents each in a nearly A$33 million market cap
MyFiziq’s (MYQ) joint venture, Body Composition Technologies (BCT), has placed second at the DXC Invitational Americas Insurtech awards.
The new tech company was one of four finalists at the second-ever DXC awards, taking out the second spot in category two. The ‘Enriching the Insurance Experience’ category invited participants to present their technology as part of the DXC insurance service suite.
BCT, which is 50 per cent owned by MyFiziq, is a software platform which allows consumers to create affordable, accessible and reliable smartphone-based body compositions to be utilised by governments, insurance agencies, medical organisations and research markets.
The technology allows users to privately identify some of the primary markers of chronic diseases like type 2 diabetes, heart disease and stroke.
DXC Technology, a Fortune 500 company, is the world’s leading independent, end-to-end IT services company. The company currently serves over 6000 clients across 70 countries.
Participating insurances and new techs were invited to work through the challenge over October 14 and 16 this year. Teams were provided with a two-hour onboarding experience on the 14th and were given four hours to pitch their technology to a panel of DXC leaders.
“I am extremely happy we received the award and to be recognised for the capabilities our solution is delivering to the insurance, wellness and mHealth markets globally. This was an amazing opportunity to showcase what we have developed to the best and biggest providers in the industry on a global scale,” said MyFiziq CEO Vlado Bosanac.
“DXC recognize the need for early detection and prevention of chronic lifestyle diseases is required worldwide to help combat the dramatic growth in type 2 diabetes and related conditions,” Vlado continued.
“Our technology is a real-time solution that gives the insurer an accurate assessment of the policyholder at the time of the application, allowing more certainty in the dynamic underwriting of policies,” he stated.
MyFiziq champions a Software as a Solution (SaaS) service that uses machine learning to create 3D avatars of its users with accurate measurements via their smartphone. These avatars can be utilised across multiple software platforms – such as an online clothes retailer, a health engine or a diet tracker.
This Software Development Kit (SDK) is offered to retail partners who can utilise the software in their own marketing or online sales databases.
Company shares remained flat today, closing at 32 cents each in a nearly A$33 million market cap.